David Metz, MD (2016-2018)

Dr. Metz is a Professor of Medicine at the Hospital of the University of Pennsylvania.

After earning his MD from the University of the Witwatersrand's Medical School, Dr. Metz was a resident at both the Albert Einstein Medical Center and the Johannesburg General Hospital. He went on to complete fellowships at Georgetown University Hospital as well as the National Institutes of Health.

Dr. Metz's clinical efforts and academic research focus on acid-peptic disorders, swallowing and esophageal disorders, gastrointestinal cancers, and Eosinophilic Esophagitis. He is currently the Gastrointestinal Division's Associate Chief for Clinical Affairs, director of the Acid-Peptic program and, co-director of both the Esophagology and Swallowing Program and the Neuroendocrine Tumor Center at the Hospital of the University of Pennsylvania.

Matthew Kulke, MD (2014-2016)

Dr. Kulke joined the staff of Dana-Farber Cancer Institute (DFCI) in 1997 and is currently an Associate Professor of Medicine at Harvard Medical School. He is also the Director of the DFCI's Program in Neuroendocrine and Carcinoid Tumors.

He received an MD from the University of California, San Francisco School of Medicine in 1992. He completed a residency in internal medicine at Brigham and Women's Hospital and went on to work as a fellow in medical oncology at the Dana-Farber Cancer Institute. Dr. Kulke also holds a masters degree in medical science from Harvard Medical School.

Dr. Kulke has led numerous clinical and translational studies in patients with gastrointestinal malignancies and neuroendocrine tumors. He has served as study chair for a national study of pancreatic cancer therapies performed by the Cancer and Leukemia group B and funded by the National Cancer Institute. His current efforts have focused on clinical and translational research in carcinoid and pancreatic neuroendocrine tumors. Dr. Kulke is the recipient of the George Canellos Award for Clinical Investigation and the Ruth Brufsky Award for Pancreatic Cancer Research. Dr. Kulke is the Immediate Past Chair of the NANETS Board of Directors. He is also chair of the Neuroendocrine Tumor Task Force for the National Cancer Institute and also serves on the advisory board for the European Neuroendocrine Tumor Society.

James Yao, MD (2012-2014)

Dr. James Yao is a Professor of Medical Oncology at the University of Texas MD Anderson Cancer Center. He also holds the Deputy Department Chair of the MD Anderson Cancer Center Department of Gastrointestinal Medical Oncology.

He earned his medical degree from Baylor College of Medicine in 1995 and completed a clinical fellowship in clinical oncology at MD Anderson Cancer Center in 2001.

Dr. Yao’s research focuses on treatment modalities for neuroendocrine tumors.

He is a member of the American Society of Clinical Oncology and the NCI Investigational Drug Steering Committee. Dr. Yao is also the Vice Chair of the NCI Neuroendocrine Task Force Committee and the NANETS Chair Emeritus.

William Maples, MD (2010-2012)

Dr. William Maples is the Chief Medical Officer for Professional Research Consultants, Inc. Following his appointment to PRC, Dr. Maples led the creation of The Institute for Healthcare Excellence, a PRC company providing a collaboration of industry experts and thought leaders focused on healthcare improvement solutions to create a culture of excellence. The Institute’s signature element is an initiative Dr. Maples helped develop and now leads to improve quality, safety, and the patient experience through more effective communication. This initiative has successfully improved both patient and provider satisfaction scores at hospitals and health enterprises across the country.

Prior to joining PRC, Dr. Maples was responsible for quality and safety throughout Mission Health in Asheville, N.C. Named one of the Top 15 Health Systems in the United States by Thomson Reuters in 2012, and Truven Health Analytics in 2013, 2014, and 2015. Mission Health is a $1.2 billion integrated health system serving western North Carolina.

Before joining Mission in December 2010, Dr. Maples was a 25-year practicing physician/oncologist and quality leader at Mayo Clinic. He also served as an Associate Professor of Oncology at Mayo’s College of Medicine and as a Clinical Professor at Brooks College of Health at the University of North Florida in Jacksonville. At Mayo, he worked with key leadership to implement a quality program, which included the creation of the Communication in Healthcare curriculum that was integral to Mayo Clinic Florida achieving top national performance ratings in patient satisfaction during his tenure.

Dr. Maples earned his undergraduate and medical degrees at the University of Wisconsin–Madison and completed his residency and fellowship in oncology at the Mayo Graduate School College of Medicine.

Lawrence Kvols, MD (2008-2010)

Dr. Kvols is a consultant in neuroendocrinology at Kvols Consulting in Placitas, New Mexico.

He graduated from Baylor College of Medicine with his MD in 1970 and went on to do an internship, residency and fellowship at John Hopkins School of Medicine. From 1973-1975 Dr. Kvols completed a fellowship in hematology and oncology at Baltimore Cancer Research Center.

From 1975-1993 was a professor of oncology at Mayo Clinic before becoming the director of clinical research at Mallinckrodt. In 1996 Dr. Kvols became the director and CEO of cancer research and treatment at the University of New Mexico. Later in his career, he joined Moffitt Cancer Center as the director of neuroendocrine cancer research until he opened his own consulting company, Kvols consulting, in 2013.

According to his colleagues, Dr. Kvols personalizes his professional interest in patients with his excellent care and bedside manner.